Your search returned 4 results.

Results
	1.	A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors: Ratner, Robert E PMID: 25603459 Year: 2015 Citation: Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May. Institution: MedStar Health Research Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1210/jc.2014-3824 Add to cart (remove)
	2.	Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial. MedStar authors: Aroda, Vanita R PMID: 31359368 Year: 2019 Citation: Advances in Therapy. 36(9):2310-2326, 2019 09. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Bailey TS, Blonde L, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M DOI: https://dx.doi.org/10.1007/s12325-019-01033-1 Add to cart (remove)
	3.	Plasma epoxyeicosatrienoic acids and dihydroxyeicosatrieonic acids, insulin, glucose and risk of diabetes: The strong heart study. MedStar authors: Howard, Barbara V Umans, Jason G PMID: 33752126 Year: 2021 Citation: EBioMedicine. 66:103279, 2021 Apr. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Denham J, Fretts AM, Gharib SA, Howard BV, Jensen PN, King IB, Lemaitre RN, McKnight B, Psaty BM, Siscovick DS, Sitlani CM, Sotoodehnia N, Totah RA, Umans JG, Zeigler M DOI: https://dx.doi.org/10.1016/j.ebiom.2021.103279 Add to cart (remove)
	4.	Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors: Ratner, Robert E PMID: 24898300 Year: 2014 Citation: Diabetes Care. 37(8):2317-25, 2014 Aug. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F DOI: http://dx.doi.org/10.2337/dc14-0001 Add to cart (remove)

Powered by Koha